GSK PLC-SPON ADR (GSK)       35.04  -0.45 (-1.27%)

35.04  -0.45 (-1.27%)

US37733W2044 - ADR

TTM
(2022-9-30)
2022
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
31.48BN/A34.11B34.10B33.75B
Non Recurring Items
-2.21BN/A-772.00M807.00M-2.05B
Minority Interest Expense
-721.00MN/A-711.00M-639.00M-623.00M
Cost Of Goods
10.89BN/A11.43B10.89B10.17B
Gross Profit
20.59BN/A22.69B23.21B23.59B
Operating Expenses
12.92BN/A14.68B15.01B14.70B
Operating Income
7.67BN/A8.01B8.20B8.88B
Interest Expense
-752.00MN/A-2.39B-1.65B-580.00M
Income Before Taxes
4.71BN/A5.44B6.97B6.22B
Income Tax
482.00MN/A346.00M580.00M953.00M
Net Income
13.70BN/A4.38B5.75B4.64B
EBITDA
10.52BN/A10.39B10.55B11.22B
 
Per Share Data
EPS Diluted Total Ops
7.05N/A2.162.852.31
Non GAAP EPS
3.083.482.832.883.10
 
Statistics
Gross Profit Margin
65.41%N/A66.50%68.06%69.88%
Profit Margin
43.54%N/A12.85%16.86%13.76%
Operating Profit Margin
24.37%N/A23.48%24.04%26.32%

All data in GBP

Charts